Outset Medical, Inc. stock is up 62.71% since 30 days ago. The next earnings date is Feb 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 December’s closed higher than November. 0% of analysts rate it a buy.
Tablo Hemodialysis System comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. Outset Medical, Inc. was incorporated in 2003 and is headquartered in California.